Terms: = Lung cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Prognosis
132 results:
1. Targeted therapeutic options in early and metastatic NSCLC-overview.
Gálffy G; Morócz É; Korompay R; Hécz R; Bujdosó R; Puskás R; Lovas T; Gáspár E; Yahya K; Király P; Lohinai Z
Pathol Oncol Res; 2024; 30():1611715. PubMed ID: 38605928
[TBL] [Abstract] [Full Text] [Related]
2. Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review.
Miao X; Chen J; Yang L; Lu H
J Cancer Res Clin Oncol; 2024 Feb; 150(3):108. PubMed ID: 38421462
[TBL] [Abstract] [Full Text] [Related]
3. Methylthioadenosine Phosphorylase and Breast cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma.
Chen Y; Du X; Gao Y; Wu H; Zhao H; Su Y
Cancer Control; 2023; 30():10732748231220805. PubMed ID: 38092371
[TBL] [Abstract] [Full Text] [Related]
4. muc1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC.
Haratake N; Ozawa H; Morimoto Y; Yamashita N; Daimon T; Bhattacharya A; Wang K; Nakashoji A; Isozaki H; Shimokawa M; Kikutake C; Suyama M; Hashinokuchi A; Takada K; Takenaka T; Yoshizumi T; Mitsudomi T; Hata AN; Kufe D
J Thorac Oncol; 2024 Mar; 19(3):434-450. PubMed ID: 37924972
[TBL] [Abstract] [Full Text] [Related]
5. Bronchial oncocytic carcinoma in an adult: a case report and literature review.
Shen YF; Wang CL; Chu ZG; Cao YD; Luo Y; Zhang YL; Cao YJ
BMC Pulm Med; 2023 Oct; 23(1):375. PubMed ID: 37803309
[TBL] [Abstract] [Full Text] [Related]
6. A case of CD74-ROS1-positive lung adenocarcinoma diagnosed by next-generation sequencing achieved long-term survival with pemetrexed regimens.
Tanaka S; Yoshimura N; Asakawa R; Tobita S; Yaga M; Ueno K
Thorac Cancer; 2023 Sep; 14(25):2618-2621. PubMed ID: 37488715
[TBL] [Abstract] [Full Text] [Related]
7. Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed.
Imai H; Wasamoto S; Tsuda T; Nagai Y; Kishikawa T; Masubuchi K; Osaki T; Miura Y; Umeda Y; Ono A; Minemura H; Yamada Y; Nakagawa J; Kozu Y; Taniguchi H; Ohta H; Kasai T; Kaira K; Kagamu H
Thorac Cancer; 2023 Sep; 14(25):2567-2578. PubMed ID: 37469246
[TBL] [Abstract] [Full Text] [Related]
8. Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies.
Dietz MV; van Kooten JP; Paats MS; Aerts JGVJ; Verhoef C; Madsen EVE; Dubbink HJ; von der Thüsen JH
ESMO Open; 2023 Aug; 8(4):101600. PubMed ID: 37453150
[TBL] [Abstract] [Full Text] [Related]
9. Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell lung cancer in Sweden.
Naik J; Beavers N; Nilsson FOL; Iadeluca L; Lowry C
Appl Health Econ Health Policy; 2023 Jul; 21(4):661-672. PubMed ID: 37173513
[TBL] [Abstract] [Full Text] [Related]
10. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
Shen Q; Liu YX; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
[TBL] [Abstract] [Full Text] [Related]
11. The multifaceted role of muc1 in tumor therapy resistance.
Jin W; Zhang M; Dong C; Huang L; Luo Q
Clin Exp Med; 2023 Sep; 23(5):1441-1474. PubMed ID: 36564679
[TBL] [Abstract] [Full Text] [Related]
12. A phase I study of an adenoviral vector delivering a muc1/CD40-ligand fusion protein in patients with advanced adenocarcinoma.
Tan TJ; Ang WXG; Wang WW; Chong HS; Tan SH; Cheong R; Chia JW; Syn NL; Shuen WH; Ba R; Kaliaperumal N; Au B; Hopkins R; Li X; Tan AC; Seet AOL; Connolly JE; Arkachaisri T; Chew V; Lajam ABM; Guo D; Chew MZW; Wasser M; Kumar P; Albani S; Toh HC
Nat Commun; 2022 Oct; 13(1):6453. PubMed ID: 36307410
[TBL] [Abstract] [Full Text] [Related]
13. Protective roles of cytoplasmic p21
Koyanagi A; Kotani H; Iida Y; Tanino R; Kartika ID; Kishimoto K; Harada M
Cell Prolif; 2022 Dec; 55(12):e13326. PubMed ID: 36054146
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis.
Talvitie EM; Liljeroos L; Vilhonen H; Orte K; Leivo I; Kallajoki M; Taimen P
Neoplasia; 2022 Oct; 32():100832. PubMed ID: 35964518
[TBL] [Abstract] [Full Text] [Related]
15. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
[TBL] [Abstract] [Full Text] [Related]
16. Antitumor efficacy of muc1-derived variable epitope library treatments in a mouse model of breast cancer.
Odales J; Servín-Blanco R; Martínez-Cortés F; Guzman Valle J; Domínguez-Romero AN; Gevorkian G; Manoutcharian K
Vaccine; 2022 Aug; 40(33):4796-4805. PubMed ID: 35788294
[TBL] [Abstract] [Full Text] [Related]
17. Atypical presentation of a rare gestational trophoblastic neoplasm: A case report.
Aamir FB; Raza Raja MH; Ahmad Zaidi SM; Noorali AA; Pervez MB; Fatimi SH
J Pak Med Assoc; 2022 Jun; 72(6):1260-1262. PubMed ID: 35751357
[TBL] [Abstract] [Full Text] [Related]
18. Multiple primary pulmonary meningioma: A case report and literature review.
Huang X; Mou YF; Ren FQ; Wang Y; Yang Y
Thorac Cancer; 2022 Aug; 13(15):2257-2259. PubMed ID: 35734847
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic impact of count of extratumoral lymphatic permeation in lung adenocarcinoma and its relation to the immune microenvironment.
Niimi T; Nakai T; Aokage K; Tane K; Miyoshi T; Samejima J; Miyazaki S; Taki T; Sakamoto N; Sakashita S; Watanabe R; Kojima M; Suzuki K; Tsuboi M; Ishii G
Cancer Sci; 2022 Apr; 113(4):1497-1506. PubMed ID: 35181964
[TBL] [Abstract] [Full Text] [Related]
20. muc1 and CD147 Are Promising Markers for the Detection of Circulating Tumor Cells in Small Cell lung cancer.
Savarese-Brenner B; Heugl M; Rath B; Schweizer C; Obermayr E; Stickler S; Hamilton G
Anticancer Res; 2022 Jan; 42(1):429-439. PubMed ID: 34969753
[TBL] [Abstract] [Full Text] [Related]
[Next]
